Align 3-phosphoshikimate 1-carboxyvinyltransferase (EC 2.5.1.19) (characterized)
to candidate GFF1943 Psest_1986 3-phosphoshikimate 1-carboxyvinyltransferase
Query= BRENDA::Q83E11 (438 letters) >FitnessBrowser__psRCH2:GFF1943 Length = 747 Score = 474 bits (1220), Expect = e-138 Identities = 247/424 (58%), Positives = 308/424 (72%), Gaps = 2/424 (0%) Query: 7 PSQGLSGEICVPGDKSISHRAVLLAAIAEGQTQVDGFLMGADNLAMVSALQQMGASIQVI 66 P L+G + VPGDKSISHR+++L ++AEG T+V+GFL G D LA + A + MG I+ Sbjct: 319 PGGSLTGHLRVPGDKSISHRSIMLGSLAEGTTEVEGFLEGEDALATIQAFRDMGVVIEGP 378 Query: 67 EDENILVVEGVGMTGLQAPPEALDCGNSGTAIRLLSGLLAGQPFNTVLTGDSSLQRRPMK 126 + V GVG+ GL+APP + GNSGT++RLLSGLLA QPF+T LTGD+SL +RPM Sbjct: 379 HQGRV-TVHGVGLHGLKAPPGPIYLGNSGTSMRLLSGLLAAQPFDTTLTGDASLSKRPMN 437 Query: 127 RIIDPLTLMGAKIDSTGNV-PPLKIYGNPRLTGIHYQLPMASAQVKSCLLLAGLYARGKT 185 R+ PL MGA I++ + PPL I G RL+G+HY++PMASAQVKSCLLLAGLYA G+T Sbjct: 438 RVAKPLREMGAVIETAPDGRPPLTIRGGQRLSGMHYEMPMASAQVKSCLLLAGLYAAGQT 497 Query: 186 CITEPAPSRDHTERLLKHFHYTLQKDKQSICVSGGGKLKANDISIPGDISSAAFFIVAAT 245 +TEPAP+RDHTER+L+ F Y + + V G KL+A I +P DISSAAFF+VAA+ Sbjct: 498 SVTEPAPTRDHTERMLRGFGYPVTVKGSTALVEPGHKLQATHIEVPADISSAAFFMVAAS 557 Query: 246 ITPGSAIRLCRVGVNPTRLGVINLLKMMGADIEVTHYTEKNEEPTADITVRHARLKGIDI 305 I GS I L VGVNPTR GVI++LK+MG DI + + E EP ADI VR A+LKGIDI Sbjct: 558 IAQGSEIVLEHVGVNPTRTGVIDILKLMGGDISLENPREVGGEPVADIRVRGAQLKGIDI 617 Query: 306 PPDQVPLTIDEFPVLLIAAAVAQGKTVLRDAAELRVKETDRIAAMVDGLQKLGIAAESLP 365 P D VPL IDEFPVL +AAA A+G+T LR A ELRVKE+DRI M DGLQ LG+ AE P Sbjct: 618 PEDLVPLAIDEFPVLFVAAACAEGRTTLRGAEELRVKESDRIQVMADGLQTLGVKAEPTP 677 Query: 366 DGVIIQGGTLEGGEVNSYDDHRIAMAFAVAGTLAKGPVRIRNCDNVKTSFPNFVELANEV 425 DG++I+GG + GEV ++ DHRIAM+F+VA A GPVRI +C NV TSFPNF+ LA Sbjct: 678 DGIVIEGGAIGSGEVWAHGDHRIAMSFSVAALRASGPVRIHDCANVATSFPNFLALAQRA 737 Query: 426 GMNV 429 GM V Sbjct: 738 GMQV 741 Lambda K H 0.318 0.137 0.392 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 925 Number of extensions: 45 Number of successful extensions: 4 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 1 Number of HSP's successfully gapped: 1 Length of query: 438 Length of database: 747 Length adjustment: 36 Effective length of query: 402 Effective length of database: 711 Effective search space: 285822 Effective search space used: 285822 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 16 ( 7.4 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 41 (21.7 bits) S2: 53 (25.0 bits)
Align candidate GFF1943 Psest_1986 (3-phosphoshikimate 1-carboxyvinyltransferase)
to HMM TIGR01356 (aroA: 3-phosphoshikimate 1-carboxyvinyltransferase (EC 2.5.1.19))
# hmmsearch :: search profile(s) against a sequence database # HMMER 3.3.1 (Jul 2020); http://hmmer.org/ # Copyright (C) 2020 Howard Hughes Medical Institute. # Freely distributed under the BSD open source license. # - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - # query HMM file: ../tmp/path.aa/TIGR01356.hmm # target sequence database: /tmp/gapView.11043.genome.faa # - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - Query: TIGR01356 [M=415] Accession: TIGR01356 Description: aroA: 3-phosphoshikimate 1-carboxyvinyltransferase Scores for complete sequences (score includes all domains): --- full sequence --- --- best 1 domain --- -#dom- E-value score bias E-value score bias exp N Sequence Description ------- ------ ----- ------- ------ ----- ---- -- -------- ----------- 2.3e-131 424.3 0.0 3.3e-131 423.8 0.0 1.2 1 lcl|FitnessBrowser__psRCH2:GFF1943 Psest_1986 3-phosphoshikimate 1- Domain annotation for each sequence (and alignments): >> lcl|FitnessBrowser__psRCH2:GFF1943 Psest_1986 3-phosphoshikimate 1-carboxyvinyltransferase # score bias c-Evalue i-Evalue hmmfrom hmm to alifrom ali to envfrom env to acc --- ------ ----- --------- --------- ------- ------- ------- ------- ------- ------- ---- 1 ! 423.8 0.0 3.3e-131 3.3e-131 1 413 [. 325 738 .. 325 740 .. 0.96 Alignments for each domain: == domain 1 score: 423.8 bits; conditional E-value: 3.3e-131 TIGR01356 1 geikipgsKSishRalllaaLaegetvvtnlLkseDtlatlealrklGakve.eekeelviegvgg..lkepeae 72 g++++pg+KSishR+++l++Laeg+t+v+++L++eD lat++a+r++G+ +e ++++++++gvg lk p lcl|FitnessBrowser__psRCH2:GFF1943 325 GHLRVPGDKSISHRSIMLGSLAEGTTEVEGFLEGEDALATIQAFRDMGVVIEgPHQGRVTVHGVGLhgLKAPPGP 399 689*************************************************666*********988899999** PP TIGR01356 73 ldlgnsGttaRlltgvlalasgevvltgdeslkkRPierlveaLrelgaeieskeeegslPlaisgplkg.give 146 ++lgnsGt++Rll+g+la+++++++ltgd sl+kRP++r+ ++Lre+ga ie + +g++Pl+i+g++++ g+++ lcl|FitnessBrowser__psRCH2:GFF1943 400 IYLGNSGTSMRLLSGLLAAQPFDTTLTGDASLSKRPMNRVAKPLREMGAVIETAP-DGRPPLTIRGGQRLsGMHY 473 ****************************************************887.69*********8888**** PP TIGR01356 147 lsgsaSsQyksalllaaplalqavtleivgeklisrpyieitLkllksfgveveeederkivvkggqkykqkeve 221 ++aS+Q+ks+llla+ l a + + v+e+ +r+++e++L ++ v+++ + + v++g+k + +++e lcl|FitnessBrowser__psRCH2:GFF1943 474 EMPMASAQVKSCLLLAG---LYAAGQTSVTEPAPTRDHTERMLRGFGYP---VTVKGS-TALVEPGHKLQATHIE 541 *****************...66778888999***********9998876...777766.889****9999999** PP TIGR01356 222 vegDaSsAafflaaaaitge.evtvenlgenstqgdkaiiivLeemGadveveeqr........dvevegasklk 287 v++D+SsAaff++aa i+++ e+++e++g n+t+++ +i++L+ mG+d+++e+ r d++v+ga +lk lcl|FitnessBrowser__psRCH2:GFF1943 542 VPADISSAAFFMVAASIAQGsEIVLEHVGVNPTRTG--VIDILKLMGGDISLENPRevggepvaDIRVRGA-QLK 613 *******************99***************..788****************************75.7** PP TIGR01356 288 gvkv.didvdsliDelptlavlaafAegetriknieelRvkEsdRiaaiaeeLeklGveveeledgllieGkkke 361 g+++ + v+ +iDe+p+l v+aa+Aeg t+++++eelRvkEsdRi+++a+ L++lGv++e+++dg++ieG+ lcl|FitnessBrowser__psRCH2:GFF1943 614 GIDIpEDLVPLAIDEFPVLFVAAACAEGRTTLRGAEELRVKESDRIQVMADGLQTLGVKAEPTPDGIVIEGG--A 686 ****88999***************************************************************..6 PP TIGR01356 362 lkgavvdtydDHRiamalavlglaaegeveiedaecvaksfPeFfevleqlg 413 + +++v ++DHRiam+++v++l+a+g+v+i+d + va+sfP+F+ ++++ g lcl|FitnessBrowser__psRCH2:GFF1943 687 IGSGEVWAHGDHRIAMSFSVAALRASGPVRIHDCANVATSFPNFLALAQRAG 738 *********************************************9998876 PP Internal pipeline statistics summary: ------------------------------------- Query model(s): 1 (415 nodes) Target sequences: 1 (747 residues searched) Passed MSV filter: 1 (1); expected 0.0 (0.02) Passed bias filter: 1 (1); expected 0.0 (0.02) Passed Vit filter: 1 (1); expected 0.0 (0.001) Passed Fwd filter: 1 (1); expected 0.0 (1e-05) Initial search space (Z): 1 [actual number of targets] Domain search space (domZ): 1 [number of targets reported over threshold] # CPU time: 0.01u 0.01s 00:00:00.02 Elapsed: 00:00:00.01 # Mc/sec: 18.72 // [ok]
This GapMind analysis is from Apr 09 2024. The underlying query database was built on Apr 09 2024.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see:
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory